These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 9066635)
1. Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Kristjansson AK; Eiriksdottir G; Ragnarsson G; Sigurdsson A; Gudmundsson J; Barkardottir RB; Jonasson JG; Egilsson V; Ingvarsson S Anticancer Res; 1997; 17(1A):93-8. PubMed ID: 9066635 [TBL] [Abstract][Full Text] [Related]
2. High frequency of LOH at chromosome 18q in human breast cancer: association with high S-phase fraction and low progesterone receptor content. Huiping C; Eiriksdottir G; Sigurdsson A; Sigurgeirsdottir JR; Barkardottir RB; Egilsson V; Ingvarsson S Anticancer Res; 1998; 18(2A):1031-6. PubMed ID: 9615760 [TBL] [Abstract][Full Text] [Related]
3. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene. Zenklusen JC; Thompson JC; Klein-Szanto AJ; Conti CJ Cancer Res; 1995 Mar; 55(6):1347-50. PubMed ID: 7882334 [TBL] [Abstract][Full Text] [Related]
4. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer. Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868 [TBL] [Abstract][Full Text] [Related]
5. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463 [TBL] [Abstract][Full Text] [Related]
6. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Koreth J; Bakkenist CJ; McGee JO Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Ragnarsson G; Eiriksdottir G; Johannsdottir JT; Jonasson JG; Egilsson V; Ingvarsson S Br J Cancer; 1999 Mar; 79(9-10):1468-74. PubMed ID: 10188892 [TBL] [Abstract][Full Text] [Related]
8. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors. Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834 [TBL] [Abstract][Full Text] [Related]
9. Genetic alteration mapping on chromosome 7 in primary breast cancer. Bièche I; Khodja A; Driouch K; Lidereau R Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778 [TBL] [Abstract][Full Text] [Related]
10. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance]. Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953 [TBL] [Abstract][Full Text] [Related]
11. Submicroscopic deletions at 7q region are associated with recurrent chromosome abnormalities in acute leukemia. Basiricò R; Pirrotta R; Fabbiano F; Mirto S; Cascio L; Pagano M; Cammarata G; Magrin S; Santoro A Haematologica; 2003 Apr; 88(4):429-37. PubMed ID: 12681970 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. Zenklusen JC; Thompson JC; Troncoso P; Kagan J; Conti CJ Cancer Res; 1994 Dec; 54(24):6370-3. PubMed ID: 7987830 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314 [TBL] [Abstract][Full Text] [Related]
14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
15. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters. Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364 [TBL] [Abstract][Full Text] [Related]
16. Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene. Zeng WR; Watson P; Lin J; Jothy S; Lidereau R; Park M; Nepveu A Oncogene; 1999 Mar; 18(11):2015-21. PubMed ID: 10208423 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at selective sites on chromosomes 13 and 17 in human breast carcinoma. Thorlacius S; Jonasdottir O; Eyfjord JE Anticancer Res; 1991; 11(4):1501-7. PubMed ID: 1746906 [TBL] [Abstract][Full Text] [Related]
18. Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. Kerr J; Leary JA; Hurst T; Shih YC; Antalis TM; Friedlander M; Crawford E; Khoo SK; Ward B; Chenevix-Trench G Oncogene; 1996 Oct; 13(8):1815-8. PubMed ID: 8895529 [TBL] [Abstract][Full Text] [Related]
19. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692 [TBL] [Abstract][Full Text] [Related]
20. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers. Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA; Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]